allogeneic hematopoietic stem cell transplantation + Pharmacological Study + CLOFARABINE + Melphalan + Sirolimus + Tacrolimus

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

allogeneic hematopoietic stem cell transplantation + Pharmacological Study + CLOFARABINE + Melphalan + Sirolimus + Tacrolimus
Treatment and conditionWhere it standsTrials
allogeneic hematopoietic stem cell transplantation + Pharmacological Study + CLOFARABINE + Melphalan + Sirolimus + Tacrolimus for myelodysplastic syndromesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1